Technical Analysis for TTPH - Tetraphase Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.3179 -2.57% -0.01
TTPH closed down 2.57 percent on Wednesday, September 18, 2019, on approximately normal volume. It ran into resistance at its 50 day moving average.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical TTPH trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 50 DMA Bearish -2.57%
1,2,3 Pullback Bullish Bullish Swing Setup -2.57%
Upper Bollinger Band Walk Strength -2.57%
Wide Bands Range Expansion -2.57%
50 DMA Support Bullish -8.15%

Older signals for TTPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections through its chemistry technology. Its principal products include eravacycline, an intravenous and oral antibiotic that use as a empiric monotherapy has completed the Phase II clinical trials for the treatment of multi-drug resistant Gram-negative infections; and eravacycline oral formulation that is in Phase I clinical trials to treat complicated urinary tract infections in intravenous-to-oral step-down therapy. The company's products that are under development comprise TP-834; and TP-271 that is in preclinical trials for the treatment of respiratory diseases caused by bacterial biothreat pathogens, as well as engages in the development of Pseudomonas/Gram-negative program. Tetraphase Pharmaceuticals, Inc. was founded in 2006 and is based in Watertown, Massachusetts.
Medicine Chemistry Pharmacology Antibiotics Multiple Drug Resistance Pyrrolidines Respiratory Diseases Pseudomonas Carbapenem Basilea Pharmaceutica Eravacycline Multi Drug Resistant Gram Negative Infections
Is TTPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.2
52 Week Low 0.226
Average Volume 511,422
200-Day Moving Average 0.9163
50-Day Moving Average 0.3247
20-Day Moving Average 0.2833
10-Day Moving Average 0.3118
Average True Range 0.0418
ADX 34.21
+DI 24.8078
-DI 12.9335
Chandelier Exit (Long, 3 ATRs ) 0.3046
Chandelier Exit (Short, 3 ATRs ) 0.3514
Upper Bollinger Band 0.3715
Lower Bollinger Band 0.1951
Percent B (%b) 0.7
BandWidth 62.266149
MACD Line 0.0033
MACD Signal Line -0.0101
MACD Histogram 0.0134
Fundamentals Value
Market Cap 16.23 Million
Num Shares 51.1 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -0.11
Price-to-Sales 58.89
Price-to-Book 2.16
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.36
Resistance 3 (R3) 0.36 0.35 0.35
Resistance 2 (R2) 0.35 0.34 0.35 0.35
Resistance 1 (R1) 0.33 0.33 0.33 0.33 0.35
Pivot Point 0.32 0.32 0.32 0.32 0.32
Support 1 (S1) 0.31 0.31 0.30 0.30 0.29
Support 2 (S2) 0.29 0.30 0.29 0.29
Support 3 (S3) 0.28 0.29 0.28
Support 4 (S4) 0.28